Goodyear Tire & Rubber Co vs Teladoc Health Inc — how do they compare? Goodyear Tire & Rubber Co trades at $4.69 (market cap $1.37B), while Teladoc Health Inc trades at $5.79 (market cap $1.01B). The key difference: Goodyear Tire & Rubber Co is the larger of the two by market cap, and Teladoc Health Inc is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Goodyear Tire & Rubber Co for 57 Days and Teladoc Health Inc for 39 Days on average.
| GT | TDOC | |
|---|---|---|
Market Cap | $1.37B | $1.01B |
Volume | 9,470,773 | 4,668,477 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $9.72 |
52-Week Low | $4.66 | $4.47 |
Typical Hold Time | 57 Days | 39 Days |
Enterprise Value | $8.72B | $1.27B |
Signals from Pluang's Aura AI — not financial advice
Goodyear Tire & Rubber (GT) trades at $4.68, down 0.21% on the day, reflecting persistent bearish technicals and weak profitability. The stock shows deeply discounted valuation ratios with a P/E of 4.69 and P/B of 0.48, but fundamentals are challenged by a net loss of $1.72 billion in 2025 and negative margins. Recent news highlights the company's ongoing turnaround efforts, including restructuring and a focus on premium tire segments, amid significant cash flow volatility and high debt levels.
The outlook remains cautious with a consensus analyst price target of $8.00 suggesting potential upside, but execution risks on margin improvement and debt management are critical. Investment opportunity hinges on successful restructuring, while risks include competitive pressures, volume declines, and macroeconomic headwinds impacting the auto sector.
Teladoc Health (TDOC) trades at $5.77, up 3.78% today but remains near multi-year lows amid ongoing profitability challenges. The stock shows bearish technical signals with mixed earnings performance, having beaten estimates in two of the last three quarters but posting consistent net losses. Recent management changes include the appointment of a new CFO and legal officer as the company focuses on stabilizing its integrated care business while grappling with BetterHelp segment weakness.
While TDOC trades at discounted valuation multiples (P/S 0.4x, P/B 0.77x) and analysts maintain a $8.83 price target, the path to profitability remains uncertain given seven consecutive quarters of negative earnings. The primary investment thesis hinges on the company's ability to monetize its chronic care platform and achieve sustainable free cash flow generation, though investor sentiment remains cautious amid ongoing losses and competitive pressures in virtual healthcare.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →